Clinical Trial Update: Soluble Fibre Supplementation in NAFLD [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating soluble fibre supplementation for non-alcoholic fatty liver disease and related conditions and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Steatosis
• Non-alcoholic Fatty Liver Disease
• Non-alcoholic Steatohepatitis

Drugs mentioned

• Soluble fibre supplementation (soluble fibre supplement)

Snippet

Sponsor: McMaster University | Conditions: Non-Alcoholic Fatty Liver Disease, Non Alcoholic Steatohepatitis | Phase 2 | Status: RECRUITING